Biotransformation of the MPTP analog trans-1-methyl-4-[4-dimethylaminophenylethenyl]-1,2,3,6-tetrahydropyridine to a fluorescent pyridinium metabolite by intact neuroblastoma cells

Toxicology and Applied Pharmacology

Volumn 137, Issue 2, 1996, Pages 163-172

  Song, Xiaoou ^a   Ehrich, Marion ^a   Flaherty, Diane ^a   Wang, You Xiong ^b   Castagnoli, Neal ^b  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GYMNOMYZA SAMOENSIS; PARKINSONIA;

3 PIPERIDEINE DERIVATIVE; AMINE OXIDASE (FLAVIN CONTAINING); CLORGYLINE; SELEGILINE;

ARTICLE; BIOTRANSFORMATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; FLUORESCENCE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; METABOLITE; NEUROBLASTOMA CELL; NEUROTOXICITY;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; BIOTRANSFORMATION; FLUORESCENT DYES; HUMANS; ISOENZYMES; MICROSCOPY, FLUORESCENCE; MONOAMINE OXIDASE; MPTP POISONING; NEUROBLASTOMA; PYRIMIDINES; SPECTROMETRY, FLUORESCENCE; TUMOR CELLS, CULTURED;

EID: 0029877142     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0069     Document Type: Article

References (40)

1. Altomare, C., Carrupt, P. A., Gaillard, P., el-Tayar, N., Testa, B., and Carotti, A. (1992). Quantitative structure-metabolism relationship analyses of MAO-mediated toxication of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and analogues. Chem. Res. Toxicol. 5, 366-375.
2. Bloomquist, J., King, E., Wright, A., Mytilineou, C., Kimura, K., Castagnoli, K., and Castagnoli, N., Jr. (1994). 1-Methyl-4-phenylpyridinium-like neurotoxicity of a pyridinium metabolite derived from haloperidol: cell culture and neurotransmitter uptake studies. J. Pharmacol. Exp. Ther. 270, 822-830.
3. Bodor, N., Prokai, L., Wu, W. M., Farag, H., Jonalaggadda, S., Kawamura, M., Simpkins, J. (1992). A strategy for delivery of peptides into the central nervous system by sequential metabolism. Science 257, 1698-1700.
4. Buckman, T. D. (1991). Toxicity of MPTP and structural analogs in clonal cell lines of neuronal origin expressing B type monamine oxidase activity. Mol. Chem. Neuropathol. 15, 87-102.
5. Chiba, K., Trevor, A., and Castagnoli, N. (1985). Metabolism of the neurotoxic tertiary amine MPTP by brain monoamine oxidase. Biochem. Biophys. Res. Commun. 120, 574-578.
6. Cohen, G., and Mytilineou, C. (1985). Studies on the mechanism of action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys. Eur. J. Pharmacol. 106, 209-210.
7. Efange, S. M., Michelso, R. H., Tan, A. K., Krueger, M. J., and Singer, T. P. (1993). Molecular size and flexibility as determinants of selectivity in the oxidation of N-methyl-1-phenyl-1,2,3,6-tetrahydropyridine analogs by monoamine oxidase A and B. J. Med. Chem. 36, 1278-1283.
8. Haugland, R. P. (1992). Molecular Probes Handbook of Fluorescent Probes and Research Chemicals. Molecular Probes, Inc., Eugene, OR.
9. Hawkins, M., and Breakfield, X. O. (1978). Monamine oxidase A and B in cultured cells. J. Neurochem. 30, 1391-1397.
10. Heikkila, R. E., Manzino, L., Cabbat, F. S., and Duboisin, R. C. (1984). Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors. Nature 311, 467-469.
11. Heikkila, R. Z., Kindt, M. V., Sensalla, P. K., Giovanni, A., Younster, S. K., McKeown, K. A. (1988). Importance of monamine oxidase A in the bioactivation of neurotoxic analogs of 1-methy-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 85, 6172-6176.
12. Hiller, S. (1991). A better way to make the medicine go down. Science 253, 1095-1096.
13. Ino, M., Cole, G. M., and Timiras, P. S. (1986). Tyrosine hydroxylase and monamine oxidase-A activity increases in differentiating human neuroblastoma after elimination of dividing cells. Dev. Br. Res. 304, 120-123.
14. +) analogs: In vivo neurotoxicity and inhibition of striatal synaptosomal dopamine uptake. Eur. J. Pharmacol. 166, 65-74.
15. Kalgutkar, A. S., and Castagnoli, N., Jr. (1993). Synthesis of novel MPTP analogs as potential monoamine oxidase B (MAO-B) inhibitors. J. Med. Chem. 35, 4165-4174.
16. Kalgutkar, A. S., Castagnoli, K., Hall, A., and Castagnoli, N., Jr. (1994). Novel 4-(aryloxy)tetrahydropyridine analogs of MPTP as monoamine oxidase A and B substrates. J. Med. Chem. 37, 944-949.
17. Langer, R. (1990). New methods of drug delivery. Science 249, 1527-1533.
18. Maret, G., el-Tayar, N., Carrupt, P. A., Testa, B., Jenner, P., and Baird, M. (1990). Toxication of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and analogs by monamine oxidase. A structure-activity relationship study. Biochem. Pharmacol. 40, 783-792.
19. Matsui, M., Kawamura, S., Shibata, K., and Muramatsu, H. (1992). Synthesis and characterization of mono-, bis-, and trissubstituted pyridinium and pyrylium dyes. Bull. Chem. Soc. Jpn. 65, 71-74.
20. Nagatsu, T., Nakano, T., Kato, T., and Higashida, H. (1981). Expression of A and B types of monamine oxidase in neuroblastoma hybrid cells. Neurochem. Int. 3, 137-142.
21. Naiman, N. A., Rollema, H., Johnson, A., and Castagnoli, N., Jr. (1990). Studies on 4-benzyl-1-methyl-1,2,3,6-tetrahydropyridine, a non-neurotoxic analog of the parkinsonian inducing agent 1-methyl-4-phenyl-1,2,3,6-ttrahydropyridine. Chem. Res. Toxicol. 3, 133-138.
22. Naoi, M., Takahashi, T., and Nagatsu, T. (1987). Metabolism of 4-methyl-4-phenyl-1,2,3,6-tetraphydropyridine in a rat pheochromocytoma cell line, PC-12. Life Sci. 41, 2655-2661.
23. Ogata, T., Myers, C., and Blumer, J. L. (1992). Determination of platelet monoamine oxidase activity by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. 575, 39-49.
24. +, the monoamine oxidase catalyzed oxidation product of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). J. Med. Chem. 28, 1432-1436.
25. Powell, J. F., and Crari, I. W. (1979). The characterization of monamine oxidase in cultured mammalian cells. J. Neurochem. 32, 521-517.
26. +-like neurotoxicity of a pyridinium metabolite derived from haloperidol: In vivo microdialysis and in vitro mitochondrial studies. J. Pharmacol. Exp. Ther. 268, 380-387.
27. Ross, R. A., Biedler, J. L., Spengler, B. A., and Reis, D. J. (1981). Neuro-transmitter-synthesizing enzymes in 14 human neuroblastoma cell lines. Cell. Mol. Neurobiol. 1, 301-311.
28. Ross, R. A., Spengler, B. A., and Biedler, J. L. (1983). Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J. Natl. Cancer Inst. 4, 741-749.
29. Sablin, S. O., Tkachenko, S. E., and Bachurin, S. O. (1991). Structure -activity study of MAO-catalyzed dehydrogenation of MPTP analogs. Doklady Acad. Sci. USSR 318, 228-231.
30. Sablin, S. O., Krueger, M. J., Singer, T. P., Bachurin, S. O., Khare, A. B., Efange, S. M. N., and Tkachenko, S. E. (1994). Interaction of tetrahydrostilbazoles with monoamine oxidase A and B. J. Med. Chem. 37, 151-157.
31. Salach, J. I., and Weyler, W. (1987). Preparation of the flavin-containing aromatic amine oxidases of human placenta and beef liver. In Methods in Enzymology (S. Kaufman, Ed.), Vol. 142 pp. 627-637. Academic Press Inc., Ltd., London.
32. Stevens, A. C., Frutos, R. P., Harvey, D. F., and Brian, A. A. (1993). Synthesis of protein-reactive (aminostyryl)pyridinium dyes. Bioconjugate Chem. 4, 19-24.
33. Subramanyam, B., Woolf, T., and Castagnoli, N., Jr. (1991). Studies on the in vitro conversion of haloperidol to a potentially neurotoxic pyridinium metabolite. Chem. Res. Toxicol. 4, 123-128.
34. Tufvesson, G. (1970). Fluorometric determination of amine oxidase activity in human blood serum with kynuramine as substrate. Scad. J. Clin. Lab. Invest. 26, 151-154.
35. +. Chem. Res. Toxicol. 1, 186-194.
36. Wu, P. H., and Dyck, L. E. (1976). Microassay for the estimation of monamine oxidase activity. Anal. Biochem. 72, 637-642.
37. Youngster, S. K., Nicklas, W. J., and Heikkila, R. E. (1989). Structure -activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. II. Evaluation of the biological activity of the pyridinium metabolites formed from the monamine oxidase-catalyzed oxidation of MPTP analogs. J. Pharmacol. Exp. Ther. 248, 828-836.
38. Zhao, Z., Leung, L., Trevor, A. J., and Castagnoli, N., Jr. (1991). Formulation in the presence of rat brain mitochondria of the 1,2,4,5-tetrahydropyridinium metabolite derived from the psychotomimetic drug phencyclidine. Chem. Res. Toxicol. 4, 426-429.
39. Zhao, Z., Dalvie, D., Naiman, N., Castagnoli, K., and Castagnoli, N., Jr. (1992). Design, synthesis, and biological evaluation of novel 4-substituted-1-methyl-1,2,3,5-tetrahydropyridine analogs of MPTP. J. Med. Chem. 35, 4473-4478.
40. Zhu, Q. S., Grimsby, J., Chen, K., and Shih, J. C. (1992). Promoter organization and activity of human monamine oxidase (MAO) A and B genes. J. Neurosci. 12, 4437-4446.